Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2a,Condition 2b,Condition 3 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,185 days,10,,CMO:0000360,serum triglyceride level,,,,191.15136,mg/dl,12.3894,39.1788,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11474,fasting (between 6 and 7 hours),,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000305,F344/DuCrlCrlj,male,185 days,9,,CMO:0000360,serum triglyceride level,,,,203.5408,mg/dl,7.9646,23.8939,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11476,fasting (between 6 and 7 hours),,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,185 days,10,,CMO:0000360,serum triglyceride level,,,,268.14288,mg/dl,14.1594,44.7758,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11478,fasting (between 6 and 7 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,57.5224,mg/dl,10.6195,23.746,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64856,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,42.47808,mg/dl,7.9646,17.8095,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64857,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,24.77888,mg/dl,2.6549,5.9365,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64858,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,50.44272,mg/dl,11.5045,25.7248,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64859,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,77.87648,mg/dl,11.5045,25.7248,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64860,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000771,WKY/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,40.70816,mg/dl,7.9646,17.8095,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64861,fasting (0 null) (for 16 hours),,,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,108.4,mg/dl,14.5,38.3634,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13192,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,89.9,mg/dl,6.73,17.8059,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13193,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000360,serum triglyceride level,,,,113.5,mg/dl,4.81,15.953,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13194,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000360,serum triglyceride level,,,,111.7,mg/dl,8.83,29.2858,MMO:0000136,serum triglyceride analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13195,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000746,SHR/Izm,male,98 days,10,,CMO:0000360,serum triglyceride level,,,,10.5,mg/dl,0.6641,2.1,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours),12448,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),fasting (for 16 hours),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000746,SHR/Izm,male,113 days,10,,CMO:0000360,serum triglyceride level,,,,23.8,mg/dl,3.8264,12.1,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours),12478,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),fasting (for 16 hours) 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,98 days,10,,CMO:0000360,serum triglyceride level,,,,11,mg/dl,1.0752,3.4,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours),12499,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),fasting (for 16 hours),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,113 days,10,,CMO:0000360,serum triglyceride level,,,,15,mg/dl,1.8025,5.7,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours),12508,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),fasting (for 16 hours) 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood triglyceride amount,,RS:0000284,OLETF,male,246 days,23,,CMO:0000360,serum triglyceride level,,,,218.77,mg/dl,13.4742,64.62,MMO:0000136,serum triglyceride analysis,carotid artery,,"Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan",,,,fasting (for 18 hours),12359,fasting (for 18 hours),,,, 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood triglyceride amount,,RS:0000313,F344/NRrrc,male,246 days,21,,CMO:0000360,serum triglyceride level,,,,131.8,mg/dl,4.5215,20.72,MMO:0000136,serum triglyceride analysis,carotid artery,,"Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan",,,,fasting (for 18 hours),12376,fasting (for 18 hours),,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000360,serum triglyceride level,,,,102.25,mg/dl,25.98,63.6377,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101917,fasting (for 16 hours),,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000360,serum triglyceride level,,,,1559.93,mg/dl,353.89,936.3049,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101918,fasting (for 16 hours),,,,